30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Meridian Bioscience Inc (VIVO)

Track

The most recent insider trading activity occurred on June 27, 2022, with a planned sale of 61,437 shares by the Chief Executive Officer. Prior to this, on February 25, 2022, the EVP & CFO purchased 4,028 shares. Another executive, EVP, Life Science, sold 20,000 shares on February 15, 2022.
Stock chart
Ticker: VIVO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Kenny John P.
Chief Executive Officer
1 sale — total 1,866,788 USD
Planned sale 27 Jun 2022
Value US$2,534,146.10 | Price 303.28 | Shares 27,018
Planned sale 24 Jun 2022
Value US$3,870,623.24 | Price 390.53 | Shares 66,262
Planned sale 23 Jun 2022
Value US$598,209.04 | Price 29.98 | Shares 19,956
Planned sale 22 Jun 2022
Value US$1,326,920.56 | Price 29.72 | Shares 44,651
Buy 25 Feb 2022
Value US$100,166.29 | Price 24.87 | Shares 4,028
Sale 15 Feb 2022
Value US$511,912.00 | Price 25.60 | Shares 20,000
Planned sale 17 Mar 2021
Value US$750,000.00 | Price 25.00 | Shares 30,000
Planned sale 10 Mar 2021
Value US$250,000.00 | Price 25.00 | Shares 10,000
Planned sale 16 Feb 2021
Value US$71,603.91 | Price 30.35 | Shares 2,359
Planned sale 12 Feb 2021
Value US$789,084.87 | Price 30.14 | Shares 26,181
Planned sale 11 Feb 2021
Value US$39,601.45 | Price 30.00 | Shares 1,320
Planned sale 8 Feb 2021
Value US$2,039,113.82 | Price 29.86 | Shares 68,288
Planned sale 8 Feb 2021
Value US$187,620.00 | Price 30.00 | Shares 6,254
Sale 8 Feb 2021
Value US$464,007.58 | Price 28.16 | Shares 16,480
Planned sale 5 Feb 2021
Value US$500,000.00 | Price 25.00 | Shares 20,000
Planned sale 5 Feb 2021
Value US$500,000.00 | Price 25.00 | Shares 20,000
Planned sale 5 Feb 2021
Value US$379,125.52 | Price 26.61 | Shares 14,250
Buy 25 Nov 2020
Value US$88,265.50 | Price 17.65 | Shares 5,000
Buy 16 Mar 2020
Value US$9,331.00 | Price 6.02 | Shares 1,550
Buy 12 Mar 2020
Value US$173,541.00 | Price 5.78 | Shares 30,000
Buy 10 Mar 2020
Value US$6,955.00 | Price 6.96 | Shares 1,000
Buy 10 Mar 2020
Value US$6,981.00 | Price 6.98 | Shares 1,000
Buy 25 Feb 2020
Value US$37,949.50 | Price 7.59 | Shares 5,000
Buy 24 Feb 2020
Value US$22,547.10 | Price 7.52 | Shares 3,000
Buy 21 Feb 2020
Value US$76,546.00 | Price 7.65 | Shares 10,000
Buy 12 Nov 2019
Value US$80,626.00 | Price 8.06 | Shares 10,000
Buy 8 Nov 2019
Value US$154,588.00 | Price 7.73 | Shares 20,000
Buy 22 May 2019
Value US$22,516.40 | Price 11.26 | Shares 2,000
Buy 16 May 2019
Value US$56,855.00 | Price 11.37 | Shares 5,000
Buy 13 May 2019
Value US$57,015.00 | Price 11.40 | Shares 5,000
Buy 8 May 2019
Value US$229,744.00 | Price 11.49 | Shares 20,000
Buy 28 Nov 2018
Value US$571.07 | Price 18.42 | Shares 31
Sale 13 Nov 2018
Value US$193,047.16 | Price 19.55 | Shares 9,876
Sale 12 Nov 2018
Value US$488,181.95 | Price 19.35 | Shares 25,225
Buy 24 Aug 2018
Value US$31,250.00 | Price 15.63 | Shares 2,000
Buy 16 Aug 2018
Value US$566.68 | Price 14.91 | Shares 38
Buy 15 May 2018
Value US$555.18 | Price 13.88 | Shares 40
Buy 23 Feb 2018
Value US$14,034.30 | Price 14.03 | Shares 1,000
Buy 13 Feb 2018
Value US$551.11 | Price 14.13 | Shares 39
Buy 7 Feb 2018
Value US$14,750.00 | Price 14.75 | Shares 1,000
Buy 28 Nov 2017
Value US$553.31 | Price 14.56 | Shares 38
Buy 24 Aug 2017
Value US$95,693.50 | Price 13.67 | Shares 7,000
Buy 14 Aug 2017
Value US$543.58 | Price 13.94 | Shares 39
Buy 15 May 2017
Value US$536.30 | Price 14.90 | Shares 36
Buy 13 Feb 2017
Value US$530.07 | Price 12.93 | Shares 41
Buy 2 Feb 2017
Value US$50,356.40 | Price 12.59 | Shares 4,000
Buy 26 Jan 2017
Value US$50,800.00 | Price 12.70 | Shares 4,000
Sale 2 Dec 2016
Value US$136,375.90 | Price 17.30 | Shares 7,883
Buy 30 Nov 2016
Value US$17,465.77 | Price 17.12 | Shares 1,020
Buy 28 Nov 2016
Value US$648.47 | Price 17.07 | Shares 38
Sale 16 Nov 2016
Value US$83,756.78 | Price 17.00 | Shares 4,926
Buy 4 Nov 2016
Value US$80,666.00 | Price 16.13 | Shares 5,000
Buy 3 Nov 2016
Value US$78,400.00 | Price 16.00 | Shares 4,900
Buy 15 Aug 2016
Value US$624.03 | Price 19.50 | Shares 32
Buy 11 Aug 2016
Value US$19,565.00 | Price 19.57 | Shares 1,000
Buy 16 May 2016
Value US$628.99 | Price 19.06 | Shares 33
Buy 29 Apr 2016
Value US$147,843.85 | Price 19.20 | Shares 7,700
Buy 12 Feb 2016
Value US$627.83 | Price 19.62 | Shares 32
Sale 9 Dec 2015
Value US$148,125.00 | Price 19.75 | Shares 7,500
Sale 1 Dec 2015
Value US$96,740.44 | Price 19.61 | Shares 4,934
Buy 23 Nov 2015
Value US$616.51 | Price 19.27 | Shares 32
Buy 6 Nov 2015
Value US$20,187.00 | Price 20.19 | Shares 1,000
Buy 10 Aug 2015
Value US$598.12 | Price 18.69 | Shares 32
Buy 11 May 2015
Value US$592.47 | Price 18.51 | Shares 32
Sale 2 Mar 2015
Value US$38,169.39 | Price 19.91 | Shares 1,917
Buy 10 Feb 2015
Value US$600.59 | Price 18.20 | Shares 33
Buy 23 Jan 2015
Value US$35,125.99 | Price 17.74 | Shares 1,980
Sale 1 Dec 2014
Value US$184,666.98 | Price 16.46 | Shares 11,219
Sale 24 Nov 2014
Value US$72,963.06 | Price 16.07 | Shares 4,539
Buy 21 Nov 2014
Value US$16,082.90 | Price 16.08 | Shares 1,000
Sale 18 Nov 2014
Value US$170,108.40 | Price 16.20 | Shares 10,500
Sale 18 Nov 2014
Value US$108,750.60 | Price 16.20 | Shares 6,713
Buy 11 Nov 2014
Value US$168,924.00 | Price 16.89 | Shares 10,000
Sale 13 Jun 2014
Value US$54,093.96 | Price 20.03 | Shares 2,700
Sale 5 Dec 2013
Value US$98,295.75 | Price 23.74 | Shares 4,141
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-06-28 2022-06-27 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
27,018 +2.2%
303.28
US$2,534,146 		27,018 +2.2% 303.28 US$2,534,146
2022-06-28 2022-06-24 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
66,262 -26.6%
390.53
US$3,870,623 		66,262 -26.6% 390.53 US$3,870,623
2022-06-24 2022-06-23 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
51,331 -4.7%
71.78
US$2,774,426 		51,331 -4.7% 71.78 US$2,774,426
2022-06-24 2022-06-22 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
44,651 -14.4%
29.72
US$1,326,921 		44,651 -14.4% 29.72 US$1,326,921
2022-02-28 2022-02-25 B Purchase
2.9
Kitzmiller Andrew S.

EVP & CFO

Officer
4,028 +53.7%
24.87
US$100,166 		4,028 +53.7% 24.87 US$100,166
2022-02-17 2022-02-15 S Sale
1.6
WELTZIEN LOURDES

EVP, Life Science

Officer
20,000 -19.4%
25.60
US$511,912 		20,000 -19.4% 25.60 US$511,912
2021-03-18 2021-03-17 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
30,000 -12.6%
25.00
US$750,000 		30,000 -12.6% 25.00 US$750,000
2021-03-11 2021-03-10 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
10,000 -4.0%
25.00
US$250,000 		10,000 -4.0% 25.00 US$250,000
2021-02-17 2021-02-16 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
2,359 -0.9%
30.35
US$71,604 		2,359 -0.9% 30.35 US$71,604
2021-02-16 2021-02-12 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
26,181 -9.5%
30.14
US$789,085 		26,181 -9.5% 30.14 US$789,085
2021-02-16 2021-02-11 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
1,320 -0.5%
30.00
US$39,601 		1,320 -0.5% 30.00 US$39,601
2021-02-10 2021-02-08 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
68,288 -21.3%
29.86
US$2,039,114 		68,288 -21.3% 29.86 US$2,039,114
2021-02-09 2021-02-08 PlS Planned sale
3.4
Baldasare Bryan T

Exec VP & CFO

Officer
6,254 -10.0%
30.00
US$187,620 		6,254 -10.0% 30.00 US$187,620
2021-02-09 2021-02-08 S Sale
3.5
Rice John McCune Jr.
Non-Executive Director
16,480 -40.3%
28.16
US$464,008 		16,480 -40.3% 28.16 US$464,008
2021-02-08 2021-02-05 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
20,000 -7.3%
25.00
US$500,000 		20,000 -7.3% 25.00 US$500,000
2021-02-08 2021-02-05 PlS Planned sale
3.4
Baldasare Bryan T

Exec VP & CFO

Officer
14,250 -19.6%
26.61
US$379,126 		14,250 -19.6% 26.61 US$379,126
2021-02-08 2021-02-05 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
20,000 -6.8%
25.00
US$500,000 		20,000 -6.8% 25.00 US$500,000
2020-11-30 2020-11-25 B Purchase
3.4
Bihl Anthony P III
Non-Executive Director
5,000 +85.5%
17.65
US$88,266 		5,000 +85.5% 17.65 US$88,266
2020-03-17 2020-03-16 B Purchase
3.7
Williams Felicia
Non-Executive Director
1,550 +37.2%
6.02
US$9,331 		1,550 +37.2% 6.02 US$9,331
2020-03-13 2020-03-12 B Purchase
3.5
Kenny John P.

Chief Executive Officer

Executive Director
30,000 +14.4%
5.78
US$173,541 		30,000 +14.4% 5.78 US$173,541
2020-03-11 2020-03-10 B Purchase
3.4
Baldasare Bryan T

Exec VP & CFO

Officer
1,000 +1.9%
6.96
US$6,955 		1,000 +1.9% 6.96 US$6,955
2020-03-11 2020-03-10 B Purchase
3.4
Baldasare Bryan T

Exec VP & CFO

Officer
1,000 +2.0%
6.98
US$6,981 		1,000 +2.0% 6.98 US$6,981
2020-02-26 2020-02-25 B Purchase
2.5
McIlwraith John
Non-Executive Director
5,000 +41.1%
7.59
US$37,950 		5,000 +41.1% 7.59 US$37,950
2020-02-26 2020-02-24 B Purchase
3.5
Rice John McCune Jr.
Non-Executive Director
3,000 +32.7%
7.52
US$22,547 		3,000 +32.7% 7.52 US$22,547
2020-02-24 2020-02-21 B Purchase
3.5
Kenny John P.

Chief Executive Officer

Executive Director
10,000 +5.0%
7.65
US$76,546 		10,000 +5.0% 7.65 US$76,546
2019-11-13 2019-11-12 B Purchase PHILLIPS DAVID Non-Executive Director
10,000 +25.9%
8.06
US$80,626 		10,000 +25.9% 8.06 US$80,626
2019-11-12 2019-11-08 B Purchase Kenny John P.

Chief Executive Officer

Executive Director
20,000 +11.2%
7.73
US$154,588 		20,000 +11.2% 7.73 US$154,588
2019-05-23 2019-05-22 B Purchase
3.5
Rice John McCune Jr.
2,000 +50.2%
11.26
US$22,516 		2,000 +50.2% 11.26 US$22,516
2019-05-20 2019-05-16 B Purchase
1.5
Anderson James M.
5,000 +71.6%
11.37
US$56,855 		5,000 +71.6% 11.37 US$56,855
2019-05-13 2019-05-13 B Purchase
1.5
PHILLIPS DAVID
Non-Executive Director
5,000 +15.0%
11.40
US$57,015 		5,000 +15.0% 11.40 US$57,015
2019-05-09 2019-05-08 B Purchase
3.5
Kenny John P.

Chief Executive Officer

Executive Director
20,000 +31.7%
11.49
US$229,744 		20,000 +31.7% 11.49 US$229,744
2019-02-25 2018-11-28 B Purchase
Ellingwood Dwight E
Non-Executive Director
31 +0.4%
18.42
US$571 		31 +0.4% 18.42 US$571
2018-11-14 2018-11-13 S Sale BALDINI LAWRENCE

EVP, Global Operations

Officer
9,876 -13.0%
19.55
US$193,047 		9,876 -13.0% 19.55 US$193,047
2018-11-14 2018-11-12 S Sale BALDINI LAWRENCE

EVP, Global Operations

Officer
25,225 -24.9%
19.35
US$488,182 		25,225 -24.9% 19.35 US$488,182
2018-08-28 2018-08-24 B Purchase McIlwraith John Non-Executive Director
2,000 +50.0%
15.63
US$31,250 		2,000 +50.0% 15.63 US$31,250
2019-02-25 2018-08-16 B Purchase
Ellingwood Dwight E
Non-Executive Director
38 +0.5%
14.91
US$567 		38 +0.5% 14.91 US$567
2019-02-25 2018-05-15 B Purchase
Ellingwood Dwight E
Non-Executive Director
40 +0.5%
13.88
US$555 		40 +0.5% 13.88 US$555
2018-02-26 2018-02-23 B Purchase McIlwraith John Non-Executive Director
1,000 +33.3%
14.03
US$14,034 		1,000 +33.3% 14.03 US$14,034
2019-02-25 2018-02-13 B Purchase
Ellingwood Dwight E
Non-Executive Director
39 +0.5%
14.13
US$551 		39 +0.5% 14.13 US$551
2018-02-07 2018-02-07 B Purchase Rice John McCune Jr. Non-Executive Director
1,000 +inf%
14.75
US$14,750 		1,000 +inf% 14.75 US$14,750
2019-02-25 2017-11-28 B Purchase
Ellingwood Dwight E
Non-Executive Director
38 +0.5%
14.56
US$553 		38 +0.5% 14.56 US$553
2017-08-25 2017-08-24 B Purchase KRAEUTLER JOHN A

Chairman and CEO

Executive Director
7,000 +2.1%
13.67
US$95,694 		7,000 +2.1% 13.67 US$95,694
2019-02-25 2017-08-14 B Purchase
Ellingwood Dwight E
Non-Executive Director
39 +0.5%
13.94
US$544 		39 +0.5% 13.94 US$544
2019-02-25 2017-05-15 B Purchase
Ellingwood Dwight E
Non-Executive Director
36 +0.5%
14.90
US$536 		36 +0.5% 14.90 US$536
2019-02-25 2017-02-13 B Purchase
Ellingwood Dwight E
Non-Executive Director
41 +0.6%
12.93
US$530 		41 +0.6% 12.93 US$530
2017-02-03 2017-02-02 B Purchase LUEKE MELISSA

Exec VP, CFO

Officer
4,000 +2.5%
12.59
US$50,356 		4,000 +2.5% 12.59 US$50,356
2017-01-30 2017-01-26 B Purchase BALDINI LAWRENCE

EVP, Pres Global Operations

Officer
4,000 +3.9%
12.70
US$50,800 		4,000 +3.9% 12.70 US$50,800
2016-12-05 2016-12-02 S Sale Elagin Vecheslav A

EVP, Research & Development

Officer
7,883 -13.0%
17.30
US$136,376 		7,883 -13.0% 17.30 US$136,376
2016-12-01 2016-11-30 B Purchase Ellingwood Dwight E Non-Executive Director
1,020 +17.1%
17.12
US$17,466 		1,020 +17.1% 17.12 US$17,466
2019-02-25 2016-11-28 B Purchase
Ellingwood Dwight E
Non-Executive Director
38 +0.6%
17.07
US$648 		38 +0.6% 17.07 US$648
2016-11-18 2016-11-16 S Sale EBERLY RICHARD

EVP; Pres, Chief Comm Officer

Officer
4,926 -9.2%
17.00
US$83,757 		4,926 -9.2% 17.00 US$83,757
2016-11-07 2016-11-04 B Purchase KRAEUTLER JOHN A

Chairman and CEO

Executive Director
5,000 +1.6%
16.13
US$80,666 		5,000 +1.6% 16.13 US$80,666
2016-11-07 2016-11-03 B Purchase BALDINI LAWRENCE

EVP, Pres Global Operations

Officer
4,900 +5.4%
16.00
US$78,400 		4,900 +5.4% 16.00 US$78,400
2019-02-25 2016-08-15 B Purchase
Ellingwood Dwight E
Non-Executive Director
32 +0.5%
19.50
US$624 		32 +0.5% 19.50 US$624
2016-08-15 2016-08-11 B Purchase McIlwraith John Non-Executive Director
1,000 +50.0%
19.57
US$19,565 		1,000 +50.0% 19.57 US$19,565
2019-02-25 2016-05-16 B Purchase
Ellingwood Dwight E
Non-Executive Director
33 +1.1%
19.06
US$629 		33 +1.1% 19.06 US$629
2016-05-02 2016-04-29 B Purchase Sazdanoff Catherine Non-Executive Director
7,700 +inf%
19.20
US$147,844 		7,700 +inf% 19.20 US$147,844
2019-02-25 2016-02-12 B Purchase
Ellingwood Dwight E
Non-Executive Director
32 +1.0%
19.62
US$628 		32 +1.0% 19.62 US$628
2015-12-10 2015-12-09 S Sale Elagin Vecheslav A

EVP, Research & Development

Officer
7,500 -12.1%
19.75
US$148,125 		7,500 -12.1% 19.75 US$148,125
2015-12-02 2015-12-01 S Sale EBERLY RICHARD

EVP,Pres Meridian Life Science

Officer
4,934 -9.6%
19.61
US$96,740 		4,934 -9.6% 19.61 US$96,740
2019-02-25 2015-11-23 B Purchase
Ellingwood Dwight E
Non-Executive Director
32 +1.0%
19.27
US$617 		32 +1.0% 19.27 US$617
2015-11-24 2015-11-06 B Purchase McIlwraith John Non-Executive Director
1,000 +100.0%
20.19
US$20,187 		1,000 +100.0% 20.19 US$20,187
2019-02-25 2015-08-10 B Purchase
Ellingwood Dwight E
Non-Executive Director
32 +1.1%
18.69
US$598 		32 +1.1% 18.69 US$598
2019-02-25 2015-05-11 B Purchase
Ellingwood Dwight E
Non-Executive Director
32 +1.1%
18.51
US$592 		32 +1.1% 18.51 US$592
2015-03-03 2015-03-02 S Sale Johnson Marviette D.

VP, Human Resources

Officer
1,917 -3.9%
19.91
US$38,169 		1,917 -3.9% 19.91 US$38,169
2019-02-25 2015-02-10 B Purchase
Ellingwood Dwight E
Non-Executive Director
33 +1.1%
18.20
US$601 		33 +1.1% 18.20 US$601
2015-01-26 2015-01-23 B Purchase Ellingwood Dwight E Non-Executive Director
1,980 +198.0%
17.74
US$35,126 		1,980 +198.0% 17.74 US$35,126
2014-12-02 2014-12-01 S Sale ROLIH SUSAN

EVP, Reg & Quality Systems

Officer
11,219 -8.8%
16.46
US$184,667 		11,219 -8.8% 16.46 US$184,667
2014-11-26 2014-11-24 S Sale EBERLY RICHARD

EVP,Pres Meridian Life Science

Officer
4,539 -9.7%
16.07
US$72,963 		4,539 -9.7% 16.07 US$72,963
2014-11-24 2014-11-21 B Purchase Ellingwood Dwight E Non-Executive Director
1,000 +inf%
16.08
US$16,083 		1,000 +inf% 16.08 US$16,083
2014-11-20 2014-11-18 S Sale KRAEUTLER JOHN A

Chairman and CEO

Executive Director
10,500 -3.7%
16.20
US$170,108 		10,500 -3.7% 16.20 US$170,108
2014-11-20 2014-11-18 S Sale LUEKE MELISSA

Exec VP, CFO

Officer
6,713 -4.8%
16.20
US$108,751 		6,713 -4.8% 16.20 US$108,751
2014-11-12 2014-11-11 B Purchase PHILLIPS DAVID Non-Executive Director
10,000 +96.0%
16.89
US$168,924 		10,000 +96.0% 16.89 US$168,924
2014-06-16 2014-06-13 S Sale READY ROBERT J Non-Executive Director
2,700 -16.5%
20.03
US$54,094 		2,700 -16.5% 20.03 US$54,094
2013-12-06 2013-12-05 S Sale Elagin Vecheslav A

EVP, Research & Development

Officer
4,141 -7.6%
23.74
US$98,296 		4,141 -7.6% 23.74 US$98,296
Explore more

More insider trading research around Meridian Bioscience Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America